Home > Insider Trading > Filing (0001562180-21-000358)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494174	H. Daniel Orenstein	C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-01-13	10,000	$10.34	68,046	No	4	M	Direct
Common Stock	Disposition	2021-01-13	10,000	$47.18	58,046	No	4	S	Direct
Common Stock	Acquisiton	2021-01-15	3,500	$10.34	61,546	No	4	M	Direct
Common Stock	Disposition	2021-01-15	3,500	$47.98	58,046	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-01-13	10,000	$0.00	10,000	$10.34
Common Stock	Stock Option (Right to Buy)	Disposition	2021-01-15	3,500	$0.00	3,500	$10.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
150,000		2026-02-10	No	4	M	Direct
146,500		2026-02-10	No	4	M	Direct

Footnotes

The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.01 to $47.51, inclusive.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.74 to $48.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019.